Physician profile
Michael Canfield
NPI 1245762186
$7,846.39
in general payments reported to CMS, 2019-2025
16 companies · $1,135 in 2025
The $1,135 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,115 · 2023: $2,785 · 2024: $811 · 2025: $1,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,731.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,901.91 | 2022-2025 | Mako, Accolade, Triathlon |
| Kairos Surgical INC | $1,200.00 | 2022 | |
| Depuy Synthes Sales INC. | $665.12 | 2023-2025 | Velys, Actis, Attune |
| Medical Device Business Services, INC. | $401.20 | 2022-2023 | |
| Smith+Nephew, INC. | $141.45 | 2023 | Trigen, Evos Mini |
| Medtronic, INC. | $124.20 | 2025 | Aquamantys(Tm) |
| Biocomposites INC | $115.99 | 2024 | |
| Orthalign INC | $91.99 | 2024 | Orthalign Plus |
| Ferring Pharmaceuticals INC. | $51.18 | 2025 | Euflexxa |
| Heraeus Medical, LLC. | $35.39 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $25.42 | 2023 | Iovera |
| Kowa Pharmaceuticals America, INC. | $23.77 | 2023 | Seglentis |
| Olympus America INC. | $18.72 | 2023 | |
| Novo Nordisk INC | $17.88 | 2023 | Wegovy |
| Fidia Pharma USA INC. | $16.84 | 2025 | Hymovis, Triluron |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Canfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.